Scribd
Upload
45 views1 page

Top 20 Global Products 2014

This document lists the top 20 global products in 2014 by sales. Humira was the top selling product with $11.8 billion in sales and 22.1% growth. Sovaldi, a treatment for hepatitis C, had the highest growth of over 13,000% and $9.4 billion in sales to rank third overall. The data is from IMS Health and covers sales through pharmaceutical distribution channels, including both prescription and some over-the-counter products.

Uploaded by

Anonymous YY8X6W
Copyright
© © All Rights Reserved
We take content rights seriously. If you suspect this is your content, claim it here.
Available Formats
Download as PDF, TXT or read online on Scribd
45 views1 page

Top 20 Global Products 2014

This document lists the top 20 global products in 2014 by sales. Humira was the top selling product with $11.8 billion in sales and 22.1% growth. Sovaldi, a treatment for hepatitis C, had the highest growth of over 13,000% and $9.4 billion in sales to rank third overall. The data is from IMS Health and covers sales through pharmaceutical distribution channels, including both prescription and some over-the-counter products.

Uploaded by

Anonymous YY8X6W
Copyright
© © All Rights Reserved
We take content rights seriously. If you suspect this is your content, claim it here.
Available Formats
Download as PDF, TXT or read online on Scribd
You are on page 1/ 1

TOP 20 GLOBAL PRODUCTS 2014

RANK
GLOBAL MARKET
HUMIRA
LANTUS
SOVALDI
ABILIFY
ENBREL
SERETIDE
CRESTOR
REMICADE
NEXIUM
MABTHERA
AVASTIN
LYRICA
HERCEPTIN
SPIRIVA
JANUVIA
COPAXONE
NOVORAPID
NEULASTA
SYMBICORT
LUCENTIS

1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20

2014
SALES
(US$ Mn)

2014
GROWTH
(LC$ %)

2013
SALES
(US$ Mn)

936,511
11,844
10,331
9,375
9,285
8,707
8,652
8,473
8,097
7,681
6,552
6,070
6,002
5,564
5,483
4,991
4,788
4,718
4,627
4,535
4,437

8.8
22.1
30.4
13,262.2
19.2
11.0
-5.3
5.6
7.7
-1.4
4.3
6.4
19.0
7.2
4.8
14.0
2.8
17.1
5.5
18.9
2.2

879,631
9,784
8,014
70
7,824
7,918
9,198
8,140
7,648
7,867
6,363
5,793
5,107
5,261
5,283
4,457
4,691
4,071
4,397
3,885
4,382

Source: IMS Health MIDAS, December 2014


US$: Sales and Rank are in US$ with quarterly exchange rates
LC$: Growth is in constant $ to normalize for exchange rate fluctuations
Growth rates in US$ are not recommended due to fluctuations in the value of the dollar
Sales cover direct and indirect pharmaceutical channel wholesaler and manufacturers
The figures above include prescription and certain over the counter data and represent manufacturer prices
Product names shown are IMS International Product names.
Products marketed around the world with different names or marketing companies are grouped together
The names generally reflect the name in the country where the product was first launched
A match on two of three criteria (local brand name, marketing corporation and active ingredient) will be
grouped together

IMS Health HQ Limited


Registered Office: 210 Pentonville Road,
London N1 9JY, UK
Registered in England and Wales, Reg. No. 3614620

210 Pentonville Road


London N1 6JY
United Kingdom

You might also like